CLINICAL PRODUCTS CENTER (CPC) for IMMUNE-MEDIATED DISEASES

根据合同，临床产品中心根据需要为所有DAIT资助和/或赞助的临床研究项目和其他NIAID资助的临床试验提供研究产品服务。需要支持的研究包括广泛的免疫调节和罕见疾病，包括：(1)哮喘和过敏性疾病；(2)自身免疫紊乱；(3)固体器官、组织和细胞移植中的免疫调节排斥反应；(4)(5)基础科学研究(阿片疫苗研究)。此外，根据需要，还将进行传染病治疗、预防和其他疫苗研究的临床试验。拟研究的调查产品包括附表一至附表六药物制剂、生物制品、作为研究干预措施的食品和其他制剂。

The Clinical Product Center under contract, provides Investigational Product Services for all DAIT-funded and/or sponsored clinical research programs and other NIAID-funded clinical trials as needed. Studies to be supported encompass a broad range of immune-mediated & rare diseases, including: (i) asthma and allergic diseases; (ii) autoimmune disorders; (iii) immune-mediated rejection in solid organ, tissue and cell transplantation; and (iv) (v) Basic Science studies (Opioid Vaccine studies). Additionally, and on an as-needed basis, clinical trials of infectious disease treatment, prevention and other vaccine studies. Investigational Products to be studied include schedule I through VI pharmaceutical agents, biologics, foods as study interventions, and other agents.